Symbols

BMGL

Basel Medical·NASDAQ

--(--)

6.65 / 10

Outperform

Fund flow score is 6.65/10 (good), with medium and large investors showing net inflows despite overall negative trend. Analyst coverage is absent (ana_eval -1). The positive capital movement partially offsets weak fundamentals, but lack of analyst guidance adds uncertainty.

Fund Flow Rating

What is the analyst consensus for BMGL?

BMGL holds a Neutral analyst rating, with 0% of experts assigning a Hold grade. Factoring in net Outflows from order flow data, the comprehensive Sentiment Score stands at 6.65/10 (Outperform).